ERBB2 and triple-negative breast carcinoma: CD31 is a sensitive and specific marker for endothelial cells [67], EGFR is highly expressed in triple negative breast cancer cells (e.g., MDA-MB-231) [68], and HER2 is highly expressed in BT474 cells [69].